Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bimolane: structure determination indicates anticancer activity is attributable to ICRF-154.

N Camerman, A Hempel, A Camerman

    Science (New York, N.Y.)
    |September 14, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nondestructive and continuous monitoring of oxygen levels in modified atmosphere packaged ready-to-eat mixed salad products using optical oxygen sensors, and its effects on sensory and microbiological counts during storage.

    Journal of food science·2013
    Same author

    Analysis of total aerobic viable counts in raw fish by high-throughput optical oxygen respirometry.

    Journal of food protection·2011
    Same author

    A superior early myocardial infarction marker. Human heart-type fatty acid-binding protein.

    Zeitschrift fur Kardiologie·2004
    Same author

    [Functional magnetic resonance imaging and dementia].

    Der Radiologe·2003
    Same author

    [Posymag3D--a positioning system for navigated transcranial magnetic stimulation].

    Biomedizinische Technik. Biomedical engineering·2002
    Same author

    Hopping transport of positrons in hydrogenated amorphous silicon.

    Physical review letters·2001

    Bimolane anticancer activity is attributed to ICRF-154, as X-ray diffraction revealed bimolane samples contained ICRF-154. Biological tests confirmed similar efficacy between the two compounds, suggesting ICRF-154 is the active agent.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Crystallography

    Background:

    • Bimolane is an investigational anticancer agent.
    • The precise chemical identity and active component of bimolane were not fully elucidated.
    • Understanding the active pharmaceutical ingredient is crucial for drug development and regulatory approval.

    Purpose of the Study:

    • To determine the chemical structure of bimolane synthesized in different locations.
    • To compare the anticancer activity of bimolane and its identified active component.
    • To clarify the pharmacological basis of bimolane's therapeutic effect.

    Main Methods:

    • X-ray diffraction analysis of bimolane crystals.
    • Comparative biological assays to evaluate anticancer activity.

    Related Experiment Videos

  • Chemical structure elucidation.

    • Main Results:

    • X-ray diffraction studies identified bimolane samples as containing the compound ICRF-154.
    • Biological testing demonstrated no significant difference in anticancer activity between bimolane and ICRF-154.
    • These findings indicate that ICRF-154 is responsible for the observed anticancer effects.

    Conclusions:

    • The anticancer activity of bimolane is primarily due to the presence and action of ICRF-154.
    • ICRF-154 should be considered the active pharmaceutical ingredient in bimolane preparations.
    • This research clarifies the chemical and pharmacological profile of bimolane.